The rationale of prevention of thrombosis by enhancing blood levels of single-chain urokinase-type plasminogen activator (scuPA)

G Dooijewaard, P A van Boheemen, D J Binnema, C Kluft

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)278-280
JournalAnnals of the New York Academy of Sciences
Publication statusPublished - 4 Dec 1992


  • Cardiovascular Diseases
  • Fibrinolysis
  • Humans
  • Models, Biological
  • Models, Cardiovascular
  • Thrombosis
  • Tissue Plasminogen Activator
  • Urokinase-Type Plasminogen Activator
  • Journal Article

Cite this